Phase I dose-escalation and -expansion study of telisotuzumab (ABT-700), an Anti-c-met antibody, in patients with advanced solid tumors
Journal
Molecular Cancer Therapeutics
Journal Volume
19
Journal Issue
5
Pages
1210-1217
Date Issued
2020
Author(s)
Strickler J.H.
LoRusso P.
Salgia R.
Kang Y.-K.
Yen C.J.
Ansell P.
Motwani M.
Wong S.
Yue H.
Wang L.
Reilly E.
Afar D.
Naumovski L.
Ramanathan R.K.
Publisher
American Association for Cancer Research Inc.
Type
journal article